Recent Finacing
Recent Raise
Antiva Biosciences is a clinical-stage biopharmaceutical company developing topical antivirals (e.g., ABI-1968) formulated for rapid epithelial uptake to treat HPV-related precancerous lesions such as CIN and AIN.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Antiva Biosciences.
